Live
- Ayija BJP Celebrates Telangana Liberation Day and Honorable Prime Minister Narendra Modi's Birthday
- Ganesh Visarjan: Peaceful Immersion Process Underway in Hyderabad, says CP
- Social media platforms must register with DIPR: Meghalaya govt
- Collective Efforts Ensure Peaceful Ganesh Immersion: Cyberabad CP
- Nagaland killings: SC closes FIR, criminal proceedings against Army personnel
- Softening of WPI inflation to cut production costs, demand surge for consumption
- ‘Humbled & honoured’, says PM Modi on receiving birthday wishes
- Atishi as Chief Minister will be national security concern: Tarun Chugh
- Praja Palana Day Celebrations at Cyberabad CPO
- Telangana Government to Announce New Policy for SMEs Tomorrow
Dr Reddy's launches Treprostinil injection in US
Representational image
Highlights
City-based pharmaceutical company Dr Reddy’s Laboratories Limited on Friday announced the launch of Treprostinil Injection in the U S market.
Hyderabad: City-based pharmaceutical company Dr Reddy's Laboratories Limited on Friday announced the launch of Treprostinil Injection in the U S market.
A therapeutic equivalent generic version of Remodulin, Treprostinil injection is approved by the U S Food and Drug Administration (USFDA).
Dr Reddy's new launch is supplied in 20 mg/20 ml, 50 mg/20 ml, 100 mg/20 ml or 200mg/20 ml vials. Treprostinil injection is a prostacyclin mimetic indicated for patients who require transition from epoprostenol, to reduce the rate of clinical deterioration, the drug maker said.
Next Story
ADVERTISEMENT
